awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q37590576-ADCC6253-DE3E-4D92-89BC-E53E28011096
Q37590576-ADCC6253-DE3E-4D92-89BC-E53E28011096
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37590576-ADCC6253-DE3E-4D92-89BC-E53E28011096
Anti-IL17A in Axial Spondyloarthritis-Where Are We At?
P2860
Q37590576-ADCC6253-DE3E-4D92-89BC-E53E28011096
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37590576-ADCC6253-DE3E-4D92-89BC-E53E28011096
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
371ce5d0bab1e218c1da360a5d260c9545a59505
P2860
Ustekinumab for the treatment of patients with active ankylosing spondylitis: results of a 28-week, prospective, open-label, proof-of-concept study (TOPAS).